#efficacy-trial

[ follow ]
fromArs Technica
2 days ago

Moderna says mRNA flu vaccine sailed through trial, beating standard shot

Moderna's new mRNA-based flu vaccine, mRNA-1010, demonstrated a 27 percent higher efficacy rate in preventing influenza infections compared to the standard flu shot in a trial with nearly 41,000 participants aged 50 and older.
Health
[ Load more ]